Cargando…

Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity

Detalles Bibliográficos
Autor principal:	Park, Jung Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352073/ https://www.ncbi.nlm.nih.gov/pubmed/37449430 http://dx.doi.org/10.5009/gnl230222

Ejemplares similares

Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
por: Lee, Jung Il
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition
por: Ciardullo, Stefano, et al.
Publicado: (2023)

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease: from basic research to clinical application
por: Yang, Ruixu, et al.
Publicado: (2022)

Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
por: Yoon, Eileen Laurel, et al.
Publicado: (2023)

The EMRG Consortium: a gate to identify the burden of metabolic (dysfunction)-associated fatty liver disease in Egypt
por: Fouad, Yasser, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
por: Yeh, Ming-Lun, et al.
Publicado: (2023)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Insidious danger for young adults: Metabolic (dysfunction)-associated fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations
por: Casciaro, Francesca, et al.
Publicado: (2021)

Editorial: The Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: Why the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) Consensus Process is Not Representative
por: Fouad, Yasser Mahrous, et al.
Publicado: (2022)

Potential Effect of a Selective Peroxisome Proliferator-activated Receptor Alpha Modulator on Metabolic Dysfunction-associated Fatty Liver Disease
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
por: Tang, Si-Ying, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Gastric Bypass Resolves Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Low-BMI Patients: A Prospective Cohort Study
por: Billeter, Adrian T., et al.
Publicado: (2022)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury
por: Saviano, Antonio, et al.
Publicado: (2021)

Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure
por: von Meijenfeldt, Fien A., et al.
Publicado: (2022)

Mapping transcriptional heterogeneity and metabolic networks in fatty livers at single-cell resolution
por: Coassolo, Laetitia, et al.
Publicado: (2022)

Tissue resolved, gene structure refined equine transcriptome
por: Mansour, T. A., et al.
Publicado: (2017)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Phenotypic heterogeneity and cooperation in the metastatic cascade
por: Young, Katherine M., et al.
Publicado: (2022)

Phenotypic and Functional Heterogeneity of Monocytes and Macrophages
por: Hellman, Lars
Publicado: (2023)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

It’s Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging
por: Joo, Sae Kyung, et al.
Publicado: (2019)

Asthma Phenotype with Metabolic Dysfunction
por: Park, Jung-Won
Publicado: (2022)

Phenotypic Heterogeneity in Attachment of Marine Bacteria toward Antifouling Copolymers Unraveled by AFM
por: El-Kirat-Chatel, Sofiane, et al.
Publicado: (2017)

Regulation of retinol‐binding protein 4 and retinol metabolism in fatty liver disease
por: Romeo, Stefano, et al.
Publicado: (2016)

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
por: Fouad, Yasser
Publicado: (2023)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6n47te5cct3ohq4q2pfhhmju4l